Phosphorylation: A fundamental regulator of steroid receptor action

Trends in Endocrinology and Metabolism

Volumn 24, Issue 10, 2013, Pages 515-524

  Treviño, Lindsey S ^a   Weigel, Nancy L ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Cell signaling; Coactivator; Phosphorylation; Steroid receptor

Indexed keywords

ANDROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GROWTH HORMONE RECEPTOR; MINERALOCORTICOID RECEPTOR; PROGESTERONE RECEPTOR A; PROGESTERONE RECEPTOR B; SERINE; STEROID RECEPTOR; THREONINE;

CHROMATIN; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; ENZYME REGULATION; HUMAN; MOLECULAR MECHANICS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION;

CELL SIGNALING; COACTIVATOR; PHOSPHORYLATION; STEROID RECEPTOR;

ANIMALS; HUMANS; PHOSPHORYLATION; RECEPTORS, STEROID; SIGNAL TRANSDUCTION;

EID: 84884416492     PISSN: 10432760     EISSN: 18793061     Source Type: Journal    
DOI: 10.1016/j.tem.2013.05.008     Document Type: Review

References (85)

1. Couse J.F., Korach K.S. Estrogen receptor null mice: what have we learned and where will they lead us?. Endocr. Rev. 1999, 20:358-417.
2. Lu N.Z., et al. International Union of Pharmacology. LXV. The pharmacology and classification of the nuclear receptor superfamily: glucocorticoid, mineralocorticoid, progesterone, and androgen receptors. Pharmacol. Rev. 2006, 58:782-797.
3. Walters K.A., et al. Molecular insights into androgen actions in male and female reproductive function from androgen receptor knockout models. Hum. Reprod. Update 2010, 16:543-558.
4. Bulynko Y.A., O'Malley B.W. Nuclear receptor coactivators: structural and functional biochemistry. Biochemistry 2011, 50:313-328.
5. Biddie S.C., et al. Genome-wide mechanisms of nuclear receptor action. Trends Endocrinol. Metab. 2010, 21:3-9.
6. Santos G.M., et al. Negative regulation by nuclear receptors: a plethora of mechanisms. Trends Endocrinol. Metab. 2011, 22:87-93.
7. Rogatsky I., et al. Alternate surfaces of transcriptional coregulator GRIP1 function in different glucocorticoid receptor activation and repression contexts. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:16701-16706.
8. Hammes S.R., Levin E.R. Recent advances in extranuclear steroid receptor actions. Endocrinology 2011, 152:4489-4495.
9. 530 facilitates hormone-dependent transcriptional activation of the chicken progesterone receptor. Mol. Endocrinol. 1994, 8:1465-1473.
10. Gioeli D., et al. Stress kinase signaling regulates androgen receptor phosphorylation, transcription, and localization. Mol. Endocrinol. 2006, 20:503-515.
11. Gordon V., et al. CDK9 regulates AR promoter selectivity and cell growth through serine 81 phosphorylation. Mol. Endocrinol. 2010, 24:2267-2280.
12. Chen S., et al. Androgen receptor serine 81 phosphorylation mediates chromatin binding and transcriptional activation. J. Biol. Chem. 2012, 287:8571-8583.
13. Hsu F.N., et al. Regulation of androgen receptor and prostate cancer growth by cyclin-dependent kinase 5. J. Biol. Chem. 2011, 286:33141-33149.
14. Lin H.K., et al. Suppression versus induction of androgen receptor functions by the phosphatidylinositol 3-kinase/Akt pathway in prostate cancer LNCaP cells with different passage numbers. J. Biol. Chem. 2003, 278:50902-50907.
15. Ha S., et al. Phosphorylation of the androgen receptor by PIM1 in hormone refractory prostate cancer. Oncogene 2012, 10.1038/onc.2012.412.
16. Linn D.E., et al. Differential regulation of androgen receptor by PIM-1 kinases via phorphorylation-dependent recruitment of distinct ubiquitin E3 ligases. J. Biol. Chem. 2012, 287:22959-22968.
17. LeGoff P., et al. Phosphorylation of the human estrogen receptor. Identification of hormone-regulated sites and examination of their influence on transcriptional activity. J. Biol. Chem. 1994, 269:4458-4466.
18. Dutertre M., Smith C.L. Ligand-independent interactions of p160/steroid receptor coactivators and CREB-binding protein (CBP) with estrogen receptor-α: regulation by phosphorylation sites in the A/B region depends on other receptor domains. Mol. Endocrinol. 2003, 17:1296-1314.
19. Duplessis T.T., et al. Phosphorylation of estrogen receptor α at serine 118 directs recruitment of promoter complexes and gene-specific transcription. Endocrinology 2011, 152:2517-2526.
20. Murphy L.C., et al. Phospho-serine-118 estrogen receptor-alpha expression is associated with better disease outcome in women treated with tamoxifen. Clin. Cancer Res. 2004, 10:5902-5906.
21. Rayala S.K., et al. P21-activated kinase 1 regulation of estrogen receptor-alpha activation involves serine 305 activation linked with serine 118 phosphorylation. Cancer Res. 2006, 66:1694-1701.
22. Holm C., et al. Phosphorylation of the oestrogen receptor alpha at serine 305 and prediction of tamoxifen resistance in breast cancer. J. Pathol. 2009, 217:372-379.
23. Tharakan R., et al. Phosphorylation of estrogen receptor alpha, serine residue 305 enhances activity. Mol. Cell. Endocrinol. 2008, 295:70-78.
24. Williams C.C., et al. Identification of four novel phosphorylation sites in estrogen receptor alpha: impact on receptor-dependent gene expression and phosphorylation by protein kinase CK2. BMC Biochem. 2009, 10:36.
25. Lucchetti C., et al. The prolyl isomerase Pin1 acts synergistically with CDK2 to regulate the basal activity of estrogen receptor α in breast cancer. PLoS ONE 2013, 8:e55355.
26. Bhatt S., et al. Phosphorylation by p38 mitogen-activated protein kinase promotes estrogen receptor α turnover and functional activity via the SCFSkp2 proteasomal complex. Mol. Cell. Biol. 2012, 32:1928-1943.
27. Lam H.M., et al. Phosphorylation of human estrogen receptor-beta at serine 105 inhibits breast cancer cell migration and invasion. Mol. Cell. Endocrinol. 2012, 358:27-35.
28. Miller A.L., et al. p38 mitogen-activated protein kinase (MAPK) is a key mediator in glucocorticoid-induced apoptosis of lymphoid cells: correlation between p38 MAPK activation and site-specific phosphorylation of the human glucocorticoid receptor at serine 211. Mol. Endocrinol. 2005, 19:1569-1583.
29. Chen W., et al. Glucocorticoid receptor phosphorylation differentially affects target gene expression. Mol. Endocrinol. 2008, 22:1754-1766.
30. Garza A.M., et al. Site-specific phosphorylation induces functionally active conformation in the intrinsically disordered N-terminal activation function (AF1) domain of the glucocorticoid receptor. Mol. Cell. Biol. 2010, 30:220-230.
31. Blind R.D., Garabedian M.J. Differential recruitment of glucocorticoid receptor phospho-isoforms to glucocorticoid-induced genes. J. Steroid Biochem. Mol. Biol. 2008, 109:150-157.
32. Itoh M., et al. Nuclear export of glucocorticoid receptor is enhanced by c-Jun N-terminal kinase-mediated phosphorylation. Mol. Endocrinol. 2002, 16:2382-2392.
33. Rogatsky I., et al. Antagonism of glucocorticoid receptor transcriptional activation by the c-Jun N-terminal kinase. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:2050-2055.
34. Galliher-Beckley A.J., et al. Glycogen synthase kinase 3beta-mediated serine phosphorylation of the human glucocorticoid receptor redirects gene expression profiles. Mol. Cell. Biol. 2008, 28:7309-7322.
35. Galliher-Beckley A.J., et al. Ligand-independent phosphorylation of the glucocorticoid receptor integrates cellular stress pathways with nuclear receptor signaling. Mol. Cell. Biol. 2011, 31:4663-4675.
36. Mercado N., et al. Restoration of corticosteroid sensitivity by p38 mitogen activated protein kinase inhibition in peripheral blood mononuclear cells from severe asthma. PLoS ONE 2012, 7:e41582.
37. Simic I., et al. A preliminary evaluation of leukocyte phospho-glucocorticoid receptor as a potential biomarker of depressogenic vulnerability in healthy adults. Psychiatry Res. 2013, 10.1016/j.psychres.2013.02.002.
38. Shen T., et al. Transcriptional hyperactivity of human progesterone receptors is coupled to their ligand-dependent down-regulation by mitogen-activated protein kinase-dependent phosphorylation of serine 294. Mol. Cell. Biol. 2001, 21:6122-6131.
39. Lange C.A., et al. Phosphorylation of human progesterone receptors at serine-294 by mitogen-activated protein kinase signals their degradation by the 26S proteasome. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:1032-1037.
40. Daniel A.R., et al. Phosphorylation-dependent antagonism of sumoylation derepresses progesterone receptor action in breast cancer cells. Mol. Endocrinol. 2007, 21:2890-2906.
41. Clemm D.L., et al. Differential hormone-dependent phosphorylation of progesterone receptor A and B forms revealed by a phosphoserine site specific monoclonal antibody. Mol. Endocrinol. 2000, 14:52-65.
42. Faivre E.J., et al. Progesterone receptor rapid signaling mediates serine 345 phosphorylation and tethering to specificity protein 1 transcription factors. Mol. Endocrinol. 2008, 22:823-837.
43. Hagan C.R., et al. ck2-dependent phosphorylation of progesterone receptors (PR) on Ser81 regulates PR-B isoform-specific target gene expression in breast cancer cells. Mol. Cell. Biol. 2011, 31:2439-2452.
44. Pierson-Mullany L.K., Lange C.A. Phosphorylation of progesterone receptor serine 400 mediates ligand-independent transcriptional activity in response to activation of cyclin-dependent protein kinase 2. Mol. Cell. Biol. 2004, 24:10542-10557.
45. Denner L.A., et al. Regulation of progesterone receptor-mediated transcription by phosphorylation. Science 1990, 250:1740-1743.
46. Beck C.A., et al. The progesterone antagonist RU486 acquires agonist activity upon stimulation of cAMP signaling pathways. Proc. Natl. Acad. Sci. U.S.A. 1993, 90:4441-4445.
47. Labriola L., et al. Heregulin induces transcriptional activation of the progesterone receptor by a mechanism that requires functional ErbB-2 and mitogen-activated protein kinase activation in breast cancer cells. Mol. Cell. Biol. 2003, 23:1095-1111.
48. Ignar-Trowbridge D.M., et al. Peptide growth factors elicit estrogen receptor-dependent transcriptional activation of an estrogen-responsive element. Mol. Endocrinol. 1993, 7:992-998.
49. Bunone G., et al. Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation. EMBO J. 1996, 15:2174-2183.
50. Nazareth L.V., Weigel N.L. Activation of the human androgen receptor through a protein kinase A signaling pathway. J. Biol. Chem. 1996, 271:19900-19907.
51. Ueda T., et al. Ligand-independent activation of the androgen receptor by interleukin-6 and the role of steroid receptor coactivator-1 in prostate cancer cells. J. Biol. Chem. 2002, 277:38087-38094.
52. Chen Z., et al. Estrogen receptor alpha mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen. J. Clin. Invest. 1999, 103:401-406.
53. Kumar P., et al. Direct interactions with Gαi and Gβγ mediate nongenomic signaling by estrogen receptor α. Mol. Endocrinol. 2007, 21:1370-1380.
54. Chambliss K.L., et al. Non-nuclear estrogen receptor alpha signaling promotes cardiovascular protection but not uterine or breast cancer growth in mice. J. Clin. Invest. 2010, 120:2319-2330.
55. Wu Q., et al. Point mutations in the ERα Gai binding domain segregate nonnuclear from nuclear receptor function. Mol. Endocrinol. 2013, 27:2-11.
56. Sen A., et al. Understanding extranuclear (nongenomic) androgen signaling: what a frog oocyte can tell us about human biology. Steroids 2011, 76:822-828.
57. Boonyaratanakornkit V., et al. Progesterone receptor contains a proline-rich motif that directly interacts with SH3 domains and activates c-Src family tyrosine kinases. Mol. Cell 2001, 8:269-280.
58. Faivre E.J., Lange C.A. Progesterone receptors upregulate Wnt-1 to induce epidermal growth factor receptor transactivation and c-Src-dependent sustained activation of Erk1/2 mitogen-activated protein kinase in breast cancer cells. Mol. Cell. Biol. 2007, 27:466-480.
59. Samarasinghe R.A., et al. Cooperativity and complementarity: synergies in non-classical adn classical glucocorticoid signaling. Cell Cycle 2012, 11:2819-2827.
60. Hammes S.R., Levin E.R. Extranuclear steroid receptors: nature and actions. Endocr. Rev. 2007, 28:726-741.
61. Narayanan R., et al. Cyclin-dependent kinase activity is required for progesterone receptor function: novel role for cyclin A/Cdk2 as a progesterone receptor coactivator. Mol. Cell. Biol. 2005, 25:264-277.
62. Wright R.H., et al. CDK2-dependent activation of PARP-1 is required for hormonal gene regulation in breast cancer cells. Genes Dev. 2012, 26:1972-1983.
63. Vicent G.P., et al. Induction of progesterone target genes requires activation of Erk and Msk kinases and phosphorylation of histone H3. Mol. Cell 2006, 24:367-381.
64. Madak-Erdogan Z., et al. Genomic collaboration of estrogen receptor α and extracellular signal-regulated kinase 2 in regulating gene and proliferation programs. Mol. Cell. Biol. 2011, 31:226-236.
65. Kumar R., McEwan I.J. Allosteric modulators of steroid hormone receptors: structural dynamics and gene regulation. Endocr. Rev. 2012, 33:271-299.
66. Dunker A.K. Signal transduction via unstructured protein conduits. Nat. Chem. Biol. 2008, 4:229-230.
67. La Montagna R., et al. Androgen receptor serine 81 mediates Pin1 interaction and activity. Cell Cycle 2012, 11:3415-3420.
68. Rajbhandari P., et al. Regulation of estrogen receptor α N-terminus conformation and function by peptidyl prolyl isomerase Pin1. Mol. Cell. Biol. 2012, 32:445-457.
69. Kino T., et al. Cyclin-dependent kinase 5 modulates the transcriptional activity of the mineralocorticoid receptor and regulates expression of brain-derived neurotrophic factor. Mol. Endocrinol. 2010, 24:941-952.
70. Chymkowitch P., et al. The phosphorylation of the androgen receptor by TFIIH directs the ubiquitin/proteasome process. EMBO J. 2011, 30:468-479.
71. Rogatsky I., et al. Potentiation of human estrogen receptor α transcriptional activation through phosphorylation of serines 104 and 106 by the cyclin A-CDK2 complex. J. Biol. Chem. 1999, 274:22296-22302.
72. Thomas R.S., et al. Phosphorylation at serines 104 and 106 by Erk1/2 MAPK is important for estrogen receptor-alpha activity. J. Mol. Endocrinol. 2008, 40:173-184.
73. Ali S., et al. Modulation of transcriptional activation by ligand-dependent phosphorylation of the human oestrogen receptor A/B region. EMBO J. 1993, 12:1153-1160.
74. Rajbhandari P., et al. Pin1 modulates ERα levels in breast cancer through inhibition of phosphorylation-dependent ubiquitination and degradation. Oncogene 2013, 10.1038/onc.2013.78.
75. Chen D., et al. Activation of estrogen receptor alpha by S118 phosphorylation involves a ligand-dependent interaction with TFIIH and participation of CDK7. Mol. Cell 2000, 6:127-137.
76. Park K-J., et al. Formation of an IKKα-dependent transcription complex is required for estrogen receptor-mediated gene activation. Mol. Cell 2005, 18:71-82.
77. Joel P.B., et al. pp90rsk1 regulates estrogen receptor-mediated transcription through phosphorylation of ser-167. Mol. Cell. Biol. 1998, 18:1978-1984.
78. Campbell R.A., et al. Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor alpha: a new model for anti-estrogen resistance. J. Biol. Chem. 2001, 276:9817-9824.
79. Guo J.P., et al. IKKepsilon phosphorylation of estrogen receptor a Ser-167 and contribution to tamoxifen resistance in breast cancer. J. Biol. Chem. 2010, 285:3676-3684.
80. Held J.M., et al. Ligand binding promotes CDK-dependent phosphorylation of ER-alpha on hinge serine 294 but inhibits ligand-independent phosphorylation of serine 305. Mol. Cancer Res. 2012, 10:1120-1132.
81. Wang R.A., et al. p21-activated kinase-1 phosphorylates and transactivates estrogen receptor-alpha and promotes hyperplasia in mammary epithelium. EMBO J. 2002, 20:5437-5447.
82. Cui Y., et al. Phosphorylation of estrogen receptor alpha blocks its acetylation and regulates estrogen sensitivity. Cancer Res. 2004, 64:9199-9208.
83. Barone I., et al. Phosphorylation of the mutant K303R estrogen receptor alpha at serine 305 affects aromatase inhibitor sensitivity. Oncogene 2010, 29:2404-2414.
84. Hamilton-Burke W., et al. Phosphorylation of estrogen receptor beta at serine 105 is associated with good prognosis in breast cancer. Am. J. Pathol. 2010, 177:1079-1086.
85. Qiu M., et al. Mitogen activated protein kinase regulates nuclear association of human progesterone receptors. Mol. Endocrinol. 2003, 17:628-642.